Scarica l'app Stockscreener
11.75
1.91%
0.22
Dopo l'orario di chiusura:
11.75
Zymeworks Inc. Borsa (ZYME) Ultime notizie
Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development - The Financial World
Zymeworks appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development - MediaNews4U
Zymeworks Strengthens Clinical Leadership with New Senior VP Appointment - TipRanks
Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development | ZYME Stock News - GuruFocus
Zymeworks Strengthens Cancer Drug Pipeline: Top Oncology Expert Takes Helm of Clinical Development - Stock Titan
Major Investment Alert: Ecor1 Capital Boosts Stake in Zymeworks! - TipRanks
Zymeworks to Announce Q1 2025 Financial Results and Host Conference Call - TipRanks
Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 | ZYME Stock News - GuruFocus
Zymeworks Inc. to Announce First Quarter 2025 Financial Results on May 8, 2025 - Nasdaq
Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - GlobeNewswire
Clinical-Stage Biotech Zymeworks Sets Q1 2025 Earnings Date: Key Updates Expected - Stock Titan
Zymeworks Inc. (ZYME): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout - Yahoo Finance
20 Stocks Insiders Bought in April After Trump’s Tariff Rollout - Insider Monkey
Zymeworks sees $3.62 million stock purchase by EcoR1 Capital - Investing.com Canada
Zymeworks Announces Participation in Upcoming Investor Conferences, Business Wires News - AsiaOne
Zymeworks Inc. sees insider purchases totaling $1.5 million By Investing.com - Investing.com UK
Major Investment Alert: Director Buys Big in Zymeworks! - TipRanks
Zymeworks Inc. sees insider purchases totaling $1.5 million - Investing.com
Ecor1 Capital, Llc Purchases 22,689 Shares of Zymeworks Inc. (NYSE:ZYME) Stock - MarketBeat
Major Investment Alert: Ecor1 Capital Buys Big in Zymeworks! - TipRanks
Ecor1 Capital’s Oleg Nodelman buys $1.23 million in Zymeworks stock By Investing.com - Investing.com Canada
Zymeworks to Engage Investors at Upcoming Conferences - TipRanks
Zymeworks Announces Participation in Upcoming Investor Conferences - The Manila Times
Clinical-Stage Biotech Zymeworks Reveals New Pipeline Insights at Two Major Healthcare Conferences - Stock Titan
Zymeworks to Present Promising Cancer Therapy Data at AACR Meeting - TipRanks
Zymeworks to Present Preclinical Data on T cell Engager and - GlobeNewswire
Game-Changing Cancer Drug Results: Zymeworks Reveals 6 Promising Treatments at AACR - Stock Titan
Zymeworks Inc. (ZYME): Among Stocks Receiving the Most Insider Love in March - Insider Monkey
EcoR1 Capital, LLC Increases Stake in Zymeworks Inc - GuruFocus
Zymeworks Inc. sees $1.64 million stock purchase by EcoR1 Capital - Investing.com Philippines
EcoR1 Capital, LLC's Strategic Acquisition of Zymeworks Inc Shar - GuruFocus
What is Leerink Partnrs’ Forecast for Zymeworks Q1 Earnings? - The AM Reporter
Insiders Are Spending Big: 15 Stocks Leading in March - Insider Monkey
Zymeworks sees over $2.8 million in stock purchases by EcoR1 Capital - Investing.com Australia
Zymeworks Inc. (NYSE:ZYME) Receives $21.00 Consensus PT from Brokerages - Defense World
Q1 Earnings Estimate for Zymeworks Issued By Lifesci Capital - Defense World
EcoR1 capital acquires $13.1 million in Zymeworks stock By Investing.com - Investing.com South Africa
EcoR1 capital acquires $13.1 million in Zymeworks stock - Investing.com India
Equities Analysts Issue Forecasts for Zymeworks Q1 Earnings - Defense World
0.15%
4.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):